NEW YORK, April 01, 2016 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased Amaya Inc. (“Amaya”) (NASDAQ:AYA) securities between June 8, 2015 and March 22, 2016.
Click here to learn about the case: http://www.wongesq.com/pslra/amaya-inc. There is no cost or obligation to you.
The complaint alleges that the Company violated federal securities laws by failing to disclose that its CEO David Baazov was involved in insider trading. On March 23, 2016, Amaya issued a press release acknowledging that Canadian securities regulators have charged Baazov with insider trading. The allegations concern the communication of privileged information involve a “former financial advisor to Amaya.”
If you suffered a loss in Amaya you have until May 24, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/amaya-inc.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: [email protected]


Bain Capital Moves to Acquire Majority Stake in Echo Marketing
NextEra Energy Stock Rises After Reaffirming Earnings and Dividend Growth Outlook
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Short Interest Rises in Trump Media Stock After $6 Billion Merger Announcement
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Grok AI Faces Global Scrutiny Over Safeguard Failures and Illegal Content on X
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force 



